
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.48 | 0.50 | 0.02 |
Shares | 97.49 | 97.49 | 0.00 |
Other | 2.02 | 2.02 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.10 | 18.78 |
Price to Book | 4.82 | 4.27 |
Price to Sales | 5.76 | 2.28 |
Price to Cash Flow | 14.68 | 15.66 |
Dividend Yield | 1.32 | 1.17 |
5 Years Earnings Growth | 4.57 | 11.17 |
Number of long holdings: 84
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 19.38 | 192.45 | -1.31% | |
Gilead | US3755581036 | 8.75 | 109.64 | -4.28% | |
Alnylam | US02043Q1076 | 7.26 | 314.94 | -2.39% | |
Ascendis Pharma AS | US04351P1012 | 5.53 | 174.96 | -0.87% | |
Amgen | US0311621009 | 5.25 | 295.27 | -1.70% | |
argenx ADR | US04016X1019 | 4.92 | 560.24 | -0.54% | |
Neurocrine | US64125C1099 | 2.63 | 133.46 | -1.08% | |
Nuvalent Inc Class A | - | 2.38 | - | - | |
Vaxcyte | US92243G1085 | 1.99 | 35.93 | -0.86% | |
Viridian Therapeutics | US92790C1045 | 1.90 | 17.04 | -0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 665.84B | 6.20 | 19.70 | 13.63 | ||
Fidelity Contrafund | 153.33B | 11.81 | 28.39 | 16.00 | ||
Fidelity Total Market Index Instl b | 111.51B | 5.68 | 19.09 | 12.90 | ||
Fidelity International Index Inst | 64.89B | 20.59 | 16.23 | 6.71 | ||
Fidelity Blue Chip Growth | 64.78B | 4.18 | 29.97 | 17.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review